Condition
Central Line
Total Trials
5
Recruiting
0
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Active Not Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05415449CompletedPrimary
Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study
NCT06451185Not ApplicableActive Not RecruitingPrimary
Statseal® for Central Venous Catheter Insertion Sites in Critical Care
NCT06708689Active Not Recruiting
Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments
NCT04211116CompletedPrimary
Central Venous Catheters in Pediatric Anesthesia and Intensive Care
NCT02314520Not ApplicableCompleted
Complications Associated With Central Venous Access in the NSICU: PICC vs CVC
Showing all 5 trials